Guwahati News Desk: World’s largest Pharma major Pfizer has announced on Friday that it has pulled out India’s application for Emergency Use Authorisation (EUA) of its COVID-19 vaccine.
After Pfizer secured clearance in the UK and Bahrain, it has become the first pharmaceutical firm to seek an emergency use authorisation from the Drugs Controller General of India (DCGI) for its COVID-19 vaccine in the country.
A company spokesperson said in a statement wrote, “In pursuance of the Emergency Use Authorisation of its COVID-19 vaccine, Pfizer participated in the Subject Expert Committee meeting of the Drug Regulatory Authority of India on February 3. Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time.”
“Pfizer remains committed to making its vaccine available for use by the Government in India and to pursuing the requisite pathway for emergency use authorisation that enables the availability of this vaccine for any future deployment,” the spokesperson added.
